PipelinePharma Logo

Generics 37

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Etizolam manufacturers

37 products found

Filters

37 products found

etizolam

Tablets 0.5 mg, 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs available in
India
Manufacturer #22627
This pharmaceutical company was founded in 2007 and has two manufacturing facilities strategically located in India. They boast over 1,800 products spanning a range of therapeutic areas, including those focused on dermatology, pain management, and possibly central nervous system disorders based on the listed divisions. The company produces both prescription medications and over-the-counter drugs, utilizing diverse dosage forms such as tablets and capsules. They maintain a strong national network for distribution and a global presence. GMP certifications are likely held due to their focus on quality manufacturing practices.

Manufacturer usually replies in 4 days

etizolam + propranolol

Tablets 0.5 mg + 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20428
The company is a progressive pharmaceutical manufacturer in India, specializing in the development, manufacturing, and marketing of pharmaceutical, OTC, and nutraceutical products. With a focus on innovation, simplicity, and cost-efficiency, the company aims to deliver high-quality healthcare solutions across India and is planning to expand globally. Committed to providing excellent quality products, the company adheres to strict standards certified by organizations like WHO, US-FDA, GMP, and ISO 9001. With a strong emphasis on quality, Viribus Healthcare ensures that its products are reliable and safe for end users, establishing itself as a trusted name in the pharmaceutical industry.

Manufacturer usually replies in 4 days

etizolam + escitalopram oxalate

Tablets, film coated 0.5 mg + 5 mg, 0.5 mg + 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20299
This pharmaceutical company focuses on developing and manufacturing high-quality products across a range of therapeutic areas to improve global health and well-being. Their portfolio includes prescription medications, over-the-counter drugs, and supplements. Key therapy areas include mental health, cardiovascular disease, and diabetes. Principal dosage forms include tablets and capsules. The company holds GMP certifications, demonstrating adherence to stringent quality standards. They also possess product patents, safeguarding their innovative formulations. Production lines are situated in a region known for its pharmaceutical manufacturing capabilities, serving both the EU and North America markets.

Manufacturer usually replies in 1 days

Want to see all 37 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible